This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring :
- M. Stephen Simes, Vice-Chairman, President and Chief Executive Officer, BioSante
BioSante Presentation at Cancer Immunotherapy Conference
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring :
- M. Stephen Simes, Vice-Chairman, President and Chief Executive Officer, BioSante
Related Videos:
- TVAX Biomedical Presentation at Cancer Immunotherapy Conference
- Prima BioMed Presentation at Cancer Immunotherapy Conference
- Inovio Presentation at Cancer Immunotherapy Conference
- Argos Therapeutics Presentation at Cancer Immunotherapy Conference
- Vaccinogen Presentation at Cancer Immunotherapy Conference
- Bavarian Presentation at Cancer Immunotherapy Conference
- Provectus Presentation at Cancer Immunotherapy Conference
- Dendreon Presentation at Cancer Immunotherapy Conference
- ImmunoCellular Therapeutics Presentation at Cancer Immunotherapy Conference
- Celldex Presentation at Cancer Immunotherapy Conference

One Trackback
[...] BioSante New Immunotherapy Approaches [...]